title: Building the Case for Clopidogrel as a World Health Organization Essential Medicine.
authors.affiliation: From the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.). amisha.patel@northwestern.edu.
authors.forename: Amisha
authors.initials: A
authors.lastname: Patel
authors.affiliation: From the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
authors.forename: Mahesh
authors.initials: M
authors.lastname: Vidula
authors.affiliation: From the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
authors.forename: Sunny P
authors.initials: SP
authors.lastname: Kishore
authors.affiliation: From the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
authors.forename: Rajesh
authors.initials: R
authors.lastname: Vedanthan
authors.affiliation: From the Departments of Preventive Medicine and Medicine-Cardiology (A.P., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL (M.V.); Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (S.P.K.); Young Professionals Chronic Disease Network, Boston, MA (S.P.K.); and Department of Medicine-Cardiology, Icahn School of Medicine at Mount Sinai, New York, NY (R.V.).
authors.forename: Mark D
authors.initials: MD
authors.lastname: Huffman
mesh_terms: D002318:Cardiovascular Diseases / Q000188:drug therapy*; D000077144:Clopidogrel; D004363:Drug Utilization; D018954:Drugs, Essential / Q000627:therapeutic use; D006291:Health Policy; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011634:Public Health; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014944:World Health Organization
chemical_list: D018954:Drugs, Essential; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine
keywords: World Health Organization; clopidogrel; drugs; essential